Live Breaking News & Updates on Kazumi Kobayashi

Stay updated with breaking news from Kazumi kobayashi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda and IDT Support Manufacturing of Johnson & Johnson's COVID-19 Vaccine


Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Monday, March 15, 2021 5:35PM IST (12:05PM GMT)
− Takeda will make manufacturing capacity available at IDT’s facilities in Germany
 
Takeda Pharmaceutical Company Limited
(TSE:4502/NYSE:TAK) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture the single-shot COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. At the end of a three-month period, the capacity will be returned to Takeda to resume critical manufacturing for the planned launch of its dengue vaccine, subject to regulatory approvals. ....

United States , Rachel Wiese , Kazumi Kobayashi , Biologika Gmb , Rajeev Venkayya , Plasma Alliance , Takeda Pharmaceutical Company Limited , German Center , Janssen Pharmaceutical Companies Of Johnson , Care Alliance , Takeda Pharmaceutical Company , Exchange Commission , Covid Rd Alliance , Government Of Japan Ministry Health Labour , Vaccine Research , Pharmaceutical Company Limited , Janssen Pharmaceutical Companies , Global Vaccine Business Unit , Health Labour , Rare Genetic , Plasma Derived Therapies , Annual Report , Media Contact , Outside Japan , Takeda Pharmaceutical , Idt Biologika Gmbh ,